Global Innovative Platforms (GIPL) Cash & Equivalents Growth (1y) (2022 - 2026)
Powered by 
Analysis
Global Innovative Platforms (GIPL) Cash & Equivalents Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 19.65% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 2.86% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -1.67% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -9.73% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 47.71% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 174.00% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 23.27% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.27% |
| Mar 31, 2026 | 109.91% |
| Dec 31, 2025 | -66.99% |
| Sep 30, 2025 | 118,753.33% |
| Jun 30, 2025 | 1,852.86% |
| Mar 31, 2025 | 26,059.23% |
| Dec 31, 2024 | 8,710.62% |
| Sep 30, 2024 | -96.39% |
| Jun 30, 2024 | 2,710.53% |
| Mar 31, 2024 | -79.87% |
| Dec 31, 2023 | -97.38% |
| Sep 30, 2023 | -99.13% |
| Jun 30, 2023 | 37.79% |
| Mar 31, 2023 | 1,030.15% |
| Dec 31, 2022 | 24,481.30% |
| Sep 30, 2022 | 18,127.86% |
| Jun 30, 2022 | -98.58% |